- Home
- Advocacy
- Latest News and Practice Data
- CAP Discusses Key Advocacy Issues During Town Hall at Annual Meeting
During the CAP 22 Annual Meeting, CAP members gathered in person and virtually to participate in an informative Advocacy Town Hall. Advocacy Town Hall moderator and Member of the Board of Governors Kalisha Hill, MD, FCAP, asked both CAP President Emily E. Volk, MD, FCAP, and Council on Government and Professional Affairs Chair Jonathan Myles, MD, FCAP, about the CAP’s advocacy agenda.
CAP members participated in an exclusive Advocacy Town Hall, where they asked questions on the latest Advocacy efforts and inquired about current federal issues impacting their practice and reimbursements. The CAP works to influence legislation of pathology at the federal and state levels of government by engaging members in advocacy efforts.
Throughout the thorough 90-minute session, panelists Dr. Volk and Dr. Myles discussed the Advocacy agenda, including some accomplishments such as how the CAP worked with the CMS to increase clinical labor rates for histotechnologists and how the CAP successfully advocated for 13 new digital pathology add-on codes for the 2023 Medicare physician fee schedule. Dr. Myles also reviewed proposed changes to CLIA-authorized laboratory director personnel requirements, the current state of the VALID Act, advocacy for the remote sign-out waivers post COVID. Dr. Myles also reviewed how the CAP is fighting to mitigate upcoming Medicare cuts and improve the Medicare physician fee payment system.
During the Q & A session, members asked questions on the VALID Act, how it will be regulated and the CAP’s role in the regulation process, how it may impact different types of laboratory settings, and how grandfathered tests were advocated by the CAP to be included in the current legislation. CAP President Dr. Volk and Dr. Myles answered questions and cleared up concerns from members.